Tenet Healthcare Corporation (NYSE:THC – Get Free Report) EVP Lisa Foo sold 24,000 shares of the firm’s stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $266.32, for a total value of $6,391,680.00. Following the completion of the sale, the executive vice president directly owned 8,053 shares of the company’s stock, valued at $2,144,674.96. This represents a 74.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Tenet Healthcare Trading Down 2.7%
NYSE:THC opened at $258.79 on Thursday. The stock has a market capitalization of $20.84 billion, a price-to-earnings ratio of 9.98, a PEG ratio of 1.01 and a beta of 1.23. Tenet Healthcare Corporation has a 1 year low of $157.58 and a 1 year high of $283.05. The stock has a fifty day moving average price of $234.93 and a two-hundred day moving average price of $210.62. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41.
Tenet Healthcare (NYSE:THC – Get Free Report) last announced its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. During the same quarter last year, the firm posted $4.02 EPS. The business’s revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, sell-side analysts anticipate that Tenet Healthcare Corporation will post 21.04 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Analysts Set New Price Targets
THC has been the topic of several research reports. UBS Group upped their target price on Tenet Healthcare from $288.00 to $308.00 and gave the company a “buy” rating in a report on Monday, July 27th. Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a research note on Monday, July 27th. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Sunday, August 23rd. Raymond James Financial reiterated an “outperform” rating and issued a $285.00 price target on shares of Tenet Healthcare in a research report on Friday, August 14th. Finally, Guggenheim raised their price objective on shares of Tenet Healthcare from $242.00 to $283.00 and gave the stock a “buy” rating in a research note on Tuesday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $273.00.
Read Our Latest Stock Analysis on Tenet Healthcare
About Tenet Healthcare
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
See Also
- Five stocks we like better than Tenet Healthcare
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
